From Systems to Synthetic Biology:
quantitative understandig for rational engineering
Building on over 10 years of research funded with over 14m € by Spanish and EU grant agencies (details here), we have developed a proprietary microbial engineering and synthetic biology toolbox that underpins a novel live biotherapeutics platform.
A novel live biotherapeutic platform for treating human lung diseases
attenuated lung bacteria able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner. It allows engineering of multiple genetic circuits to specifically target and deliver payloads. Our platform is based on

Infectious diseases
TISSUE REGENERATION

Chronic obstructive
pulmonary disease
Infectious diseases
Cystic Fibrosis
Infectious diseases
IMMUNE SYSTEM MODULATION

Asthma
Lung Cancer
Publications by scientific team








Pulmobiotics | Platform | Respiratory diseases | Partners | Team | Contact